Access To Medicines Project

Subject Areas

Home

In the News

News clips mentioning Essential Action's work.

News Releases

Biogenerics

U.S. Congress is considering legislation that will create an FDA approval process for generic versions of biotech drugs.

Drug Monopoly Enforcement Agenda

Information on initiatives that seek to protect drug monopolies under the guise of fighting counterfeits, including the "Anti-Counterfeiting" Trade Agreement (ACTA).

Pharmaceutical Industry Transparency Issues

Essential Action campaign-related materials to promote transparency around Big Pharma's operations.

Trade Agreements

Bilateral and regional trade agreements are threatening to strip away the flexibilities that developing countries maintain under international trade rules.

World Trade Organization

A key concern is how generic drug manufacturers can achieve economies of scale under WTO rules.

Country Disputes and Other Issues

Seeking to lower medicines prices at the national level.

Resolution Affirming the Doha Declaration

The U.S. Congress is considering resolutions calling on the administration not to pressure countries using trade rule flexibilities to promote access to medicines, and supporting new mechanisms to promote R&D.


Publications and Papers

Links to a variety of published papers on which we have worked recently.

Fact Sheets

Easy-to-understand materials on key access-to-medicines issues.


Home

Archives

2010

September 0 entries
August 0 entries
July 0 entries
June 0 entries
May 0 entries
April 0 entries
March 0 entries
February 0 entries
January 0 entries

2009

December 0 entries
November 9 entries
October 6 entries
September 5 entries
August 2 entries
July 13 entries
June 7 entries
May 4 entries
April 2 entries
March 0 entries
February 1 entries
January 3 entries

2008

December 2 entries
November 1 entries
October 1 entries
September 1 entries
August 6 entries
July 1 entries
June 1 entries
May 21 entries
April 11 entries
March 9 entries
February 8 entries
January 1 entries

2007

December 1 entries
November 7 entries
October 4 entries
September 10 entries
August 1 entries
July 3 entries
June 6 entries
May 11 entries
April 3 entries
March 3 entries
February 0 entries
January 1 entries

2006

December 0 entries
November 0 entries
October 0 entries
September 2 entries
August 4 entries
July 0 entries
June 0 entries
May 0 entries
April 0 entries
March 0 entries
February 0 entries
January 1 entries

2005

December 2 entries
November 0 entries
October 0 entries
September 0 entries
August 0 entries
July 1 entries
June 0 entries
May 0 entries
April 0 entries
March 1 entries
February 0 entries
January 0 entries

2004

December 0 entries
November 0 entries
October 0 entries
September 0 entries
August 0 entries
July 1 entries
June 0 entries
May 1 entries
April 1 entries
March 2 entries
February 0 entries
January 1 entries

2003

December 1 entries
November 0 entries
October 2 entries
September 1 entries
August 0 entries
July 1 entries
June 0 entries
May 0 entries
April 0 entries
March 0 entries
February 1 entries
January 0 entries

2002

December 0 entries
November 1 entries
October 0 entries
September 0 entries
August 0 entries
July 1 entries
June 0 entries
May 0 entries
April 0 entries
March 0 entries
February 0 entries
January 1 entries

2001

December 0 entries
November 0 entries
October 1 entries
September 0 entries
August 1 entries
July 1 entries
June 0 entries
May 1 entries
April 2 entries
March 2 entries
February 0 entries
January 1 entries

2000

December 0 entries
November 0 entries
October 0 entries
September 0 entries
August 0 entries
July 0 entries
June 0 entries
May 0 entries
April 0 entries
March 0 entries
February 0 entries
January 0 entries

1999

December 0 entries
November 0 entries
October 1 entries
September 1 entries
August 1 entries

ACCESS TO MEDICINES BULLETIN

Essential Action's free Global Access to Medicines e-Bulletin aims to be a reliable and easy-to-use resource for those who
want to keep up to date on key issues and the latest developments related to access to medicines in the developing world. Subscribe here.

To view all Global Access to Medicines e-Bulletins click here.

Contact Information

Essential Action's Access to Medicines Project
P.O. Box 19405
Washington, D.C. 20036
USA

tel: 1-202-387-8030
fax: 1-202-234-5176

E-mail:
Robert Weissman, Director
rob@essential.org

Jim Donahue, Attorney
Focus: Pharmaceutical Industry Transparency
jdonahue@essential.org

Peter Maybarduk, Attorney
Focus: Technical Assistance for IP-medicines issues; Counterfeit Drugs
peter.maybarduk@essentialinformation.org

Sarah Rimmington, Attorney
Focus: Advocacy & Communications; Biogenerics; IMF & Health
srimmington@essentialinformation.org

About Us

Essential Action's Access to Medicines Project is working to overcome patent and other intellectual property barriers to affordable medicines. Read more About Us